Establishing a Virtual Health Community Management Model for Pre-Diabetes Patients

Sun Yat-sen University

Status

Not yet enrolling

Conditions

Prediabetes

Treatments

Other: Pre-diabetes Virtual Community

Study type

Interventional

Funder types

Other

Identifiers

NCT07354997

RG2023-262-03

Details and patient eligibility

About

This study builds upon the previously developed virtual health community platform, aiming to address the group characteristics and psychological traits of prediabetic patients. By employing intervention mapping to construct a group interaction management model, it seeks to develop a mobile platform integrating "gamified knowledge acquisition and motivation", "immersive lifestyle practice experiences", and "sustained community interaction management". The primary focus is on fostering patients' continuous and proactive engagement. Subsequently, a single-arm controlled trial will validate the model's efficacy, aiming to address the health management challenges faced by China's substantial prediabetic population. This initiative seeks to provide theoretical foundations and practical support for primary prevention strategies targeting other chronic diseases and at-risk cohorts.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

those who meet the 1999 WHO diagnostic criteria and the American Diabetes Association (ADA) 2010 definition for pre-diabetes (impaired fasting glucose (IFG): 6.1 mmol/L ≤ fasting plasma glucose (FPG) < 7.0 mmol/L and 2 h plasma glucose (2-hPG) after a 75 g oral glucose tolerance test (OGTT) < 7.80 mmol/L and impaired glucose tolerance (IGT): FPG<7.0 mmol/L and 7.8 mmol/L ≤ 2 hPG OGTT < 11.1 mmol/L], or HbA1c: 5.7-6.4%; age ≥18 years; (3) clear awareness and comprehension ability; able to use a smartphone and have access to internet at home; willing to participate and sign the informed consent; understand the purpose, procedure and nature of the study.

Exclusion criteria

those who have significant cognitive impairment or mental disorders; complicated with severe malignant tumours; complicated with severe acute or chronic complications such as blindness, heart failure and end-stage renal disease.